Skip to main content

Jose Fernando Rodríguez Palomares

Institutions of which they are part

Main researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Jose Fernando Rodríguez Palomares

Institutions of which they are part

Main researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

RESULTADOS EN PACIENTES ADULTOS CON VÁLVULA AÓRTICA BICÚSPIDE: PREDICTORES DE DEGENERACIÓN VALVULAR Y DILATACIÓN AÓRTICA BASADOS EN ANOMALÍAS DE FLUJO AÓRTICO Y ACTIVIDAD BIOMECÁNICA Y METABÓLICA.

IP: Jose Fernando Rodríguez Palomares
Collaborators: -
Funding agency: -Sociedad Española de Cardiologia
Funding: 15000
Reference: SEC/INV.CLINICA/2021/RODRIGUEZ
Duration: 27/10/2021 - 26/10/2022

CARdiomyopathy in type 2 DIAbetes mellitus

IP: Jose Fernando Rodríguez Palomares
Collaborators: Ignacio Ferreira González, Clara Badia Molins
Funding agency: EUROPEAN COMMISSION
Funding: 50879.38
Reference: CARDIATEAM_IMI22017
Duration: 01/03/2019 - 28/02/2026

Aneurisma aterosclerótico de aorta torácica descendente y abdominal: predictores biomecánicos, histológicos y hemodinámicos de dilatación aórtica y eventos adversos

IP: Jose Fernando Rodríguez Palomares
Collaborators: Sergi Bellmunt Montoya, Aroa Ruiz Muñoz, Lydia Dux-Santoy Hurtado, Ruperto Olivero Soldevila
Funding agency: Instituto de Salud Carlos III
Funding: 127050
Reference: PI19/01480
Duration: 01/01/2020 - 30/06/2024

CardioP3T: Nuevos biomarcadores de diagnóstico y pronóstico en patología cardíaca a partir de técnicas de imagen híbrida PET-RM

IP: Jose Fernando Rodríguez Palomares
Collaborators: Lydia Dux-Santoy Hurtado, Andrea Guala
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 138065.8
Reference: RTC2019-007280-1
Duration: 01/01/2020 - 31/12/2023

Ministerio de Ciencia

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

Related professionals

Cristina Vetoret Vázquez

Cristina Vetoret Vázquez

Research assistant
Clinical Neuroimmunology
Read more
Melissa Bradbury Lobato

Melissa Bradbury Lobato

Biomedical Research in Gynaecology
Read more
Norberto Núñez Seral

Norberto Núñez Seral

Tècnic/a Superior Recerca
High Technology Unit (UAT)
Preclinical Core Facilities
Core Facilities Area
Read more
María  Puigcerver  Mas

María Puigcerver Mas

Physiology and Pathophysiology of the Digestive Tract
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.